However, in a second study, Verthelyi and colleagues [30] reported that intraperitoneal injection of DNase I in young NZB/NZW mice did not delay the onset, or reduce the severity, of glomerulonephritis, or prolong survival. This evidence concerns the gene DNASE1 and glomerulonephritis.